• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎患者纤维化的生化标志物:与凝血酶原时间、血小板计数及年龄-血小板指数的比较

Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index.

作者信息

Myers Robert P, De Torres Mercedes, Imbert-Bismut Françoise, Ratziu Vlad, Charlotte Frédéric, Poynard Thierry

机构信息

Department of Gastroenterology and Hepatology, Groupe Hospitalier Pitié-Salpêtriére, Paris, France.

出版信息

Dig Dis Sci. 2003 Jan;48(1):146-53. doi: 10.1023/a:1021702902681.

DOI:10.1023/a:1021702902681
PMID:12645802
Abstract

As an alternative to liver biopsy, an index of five biochemical markers (alpha2-macroglobulin, apolipoprotein A1, haptoglobin, total bilirubin, gamma-glutamyl-transpeptidase) has been shown to predict the severity of hepatitis C-related fibrosis. The objective of this study was to compare this index with other markers frequently used for this purpose (prothrombin time, platelets, age-platelet index). In 323 hepatitis C-infected patients, the discriminative values of these markers for F2-F4 fibrosis (by the METAVIR classification) were compared. By multiple logistic regression analysis, only the five-marker index (P < 0.0001) and prothrombin time (P = 0.02) were independently predictive of F2-F4 fibrosis. For this outcome, the area under the receiver operating characteristic curve was significantly higher for the five-marker index (0.836 +/- 0.024) than the age-platelet index (P = 0.002), and the platelet count and prothrombin time (P < 0.001), indicating greater diagnostic value. The addition of the latter markers to the five-marker index proved unhelpful for increasing its accuracy. In conclusion, an index of five biochemical markers accurately predicts significant hepatitis C-related fibrosis and is superior to traditional markers.

摘要

作为肝活检的替代方法,一种由五种生化标志物(α2-巨球蛋白、载脂蛋白A1、触珠蛋白、总胆红素、γ-谷氨酰转肽酶)组成的指标已被证明可预测丙型肝炎相关纤维化的严重程度。本研究的目的是将该指标与常用于此目的的其他标志物(凝血酶原时间、血小板、年龄-血小板指数)进行比较。在323例丙型肝炎感染患者中,比较了这些标志物对F2-F4纤维化(根据METAVIR分类)的判别价值。通过多因素逻辑回归分析,只有五标志物指标(P<0.0001)和凝血酶原时间(P=0.02)可独立预测F2-F4纤维化。对于这一结果,五标志物指标的受试者工作特征曲线下面积(0.836±0.024)显著高于年龄-血小板指数(P=0.002),以及血小板计数和凝血酶原时间(P<0.001),表明其诊断价值更大。将后几种标志物添加到五标志物指标中并不能提高其准确性。总之,一种由五种生化标志物组成的指标可准确预测显著的丙型肝炎相关纤维化,且优于传统标志物。

相似文献

1
Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index.慢性丙型肝炎患者纤维化的生化标志物:与凝血酶原时间、血小板计数及年龄-血小板指数的比较
Dig Dis Sci. 2003 Jan;48(1):146-53. doi: 10.1023/a:1021702902681.
2
Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.血清生化标志物能准确预测HIV与丙型肝炎病毒合并感染患者的肝纤维化情况。
AIDS. 2003 Mar 28;17(5):721-5. doi: 10.1097/00002030-200303280-00010.
3
Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.肝纤维化的生化标志物:与慢性丙型肝炎患者既往特征的比较
Am J Gastroenterol. 2002 Sep;97(9):2419-25. doi: 10.1111/j.1572-0241.2002.05997.x.
4
The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.Forns指数、血小板计数及AST与血小板比值指数衍生纤维化指数对丙型肝炎病毒相关显著肝纤维化和肝硬化预测的诊断准确性。
Scand J Clin Lab Invest. 2014 Apr;74(3):240-7. doi: 10.3109/00365513.2013.879392. Epub 2014 Jan 24.
5
Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.非侵入性标志物在预测慢性乙型肝炎患者肝硬化中的作用。
J Gastroenterol Hepatol. 2010 Jan;25(1):94-100. doi: 10.1111/j.1440-1746.2009.05953.x. Epub 2009 Sep 27.
6
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.丙型肝炎病毒感染患者肝纤维化的生化标志物:一项前瞻性研究。
Lancet. 2001 Apr 7;357(9262):1069-75. doi: 10.1016/S0140-6736(00)04258-6.
7
Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.Fibro-α评分作为一种简单且有用的非侵入性检测方法,用于预测慢性丙型肝炎患者的显著肝纤维化。
Arab J Gastroenterol. 2011 Jun;12(2):74-9. doi: 10.1016/j.ajg.2011.04.006. Epub 2011 May 17.
8
"Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C."Liverscore" 可预测慢性丙型肝炎的肝纤维化和活动度。
World J Gastroenterol. 2011 Nov 7;17(41):4607-13. doi: 10.3748/wjg.v17.i41.4607.
9
Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.γ-谷氨酰转肽酶与血小板比值指数是预测中国慢性乙型肝炎患者肝纤维化的良好非侵入性生物标志物。
J Int Med Res. 2016 Dec;44(6):1302-1313. doi: 10.1177/0300060516664638. Epub 2016 Nov 11.
10
Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.与METAVIR评分相比,五种非侵入性生物标志物在预测慢性丙型肝炎病毒(HCV)单感染患者肝纤维化方面的可靠性有限。
Pathol Res Pract. 2014 Dec;210(12):922-8. doi: 10.1016/j.prp.2014.07.005. Epub 2014 Jul 22.

引用本文的文献

1
Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters.直接作用抗病毒药物(DAAs)清除 HCV 对肝硬度、肝纤维化分期和代谢/细胞参数的影响。
Viruses. 2024 Feb 27;16(3):371. doi: 10.3390/v16030371.
2
GlycoFibroTyper: A Novel Method for the Glycan Analysis of IgG and the Development of a Biomarker Signature of Liver Fibrosis.糖基纤维分型仪:一种用于 IgG 聚糖分析的新方法和肝纤维化生物标志物特征的建立。
Front Immunol. 2022 Feb 7;13:797460. doi: 10.3389/fimmu.2022.797460. eCollection 2022.
3
Uncertainty of Liver Cirrhosis Diagnosis and Use of Elastography.

本文引用的文献

1
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial.
J Viral Hepat. 2002 Mar;9(2):128-33. doi: 10.1046/j.1365-2893.2002.00341.x.
2
Hepatitis C virus infection.丙型肝炎病毒感染
N Engl J Med. 2001 Jul 5;345(1):41-52. doi: 10.1056/NEJM200107053450107.
3
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.慢性丙型肝炎患者肝纤维化进展的发生率及危险因素
肝硬化诊断的不确定性与弹性成像的应用
Cureus. 2021 Sep 30;13(9):e18411. doi: 10.7759/cureus.18411. eCollection 2021 Sep.
4
Platelet count is closely associated with the severity of liver injury in patients with chronic hepatitis B virus infection: A cross-sectional study.血小板计数与慢性乙型肝炎病毒感染患者肝损伤的严重程度密切相关:一项横断面研究。
Exp Ther Med. 2020 Jul;20(1):243-250. doi: 10.3892/etm.2020.8703. Epub 2020 Apr 29.
5
Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome.化疗期间无创肝纤维化指标及脾脏大小的变化:奥沙利铂诱导的窦性阻塞综合征的潜在标志物
Medicine (Baltimore). 2016 Jan;95(2):e2454. doi: 10.1097/MD.0000000000002454.
6
Non-invasive serum fibrosis markers: A study in chronic hepatitis.非侵入性血清纤维化标志物:慢性肝炎研究。
Bioimpacts. 2015;5(1):17-23. doi: 10.15171/bi.2015.05. Epub 2015 Feb 22.
7
Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.用于检测囊性纤维化成人肝脏疾病的非侵入性方法,包括瞬时弹性成像。
Can J Gastroenterol Hepatol. 2015 Apr;29(3):139-44. doi: 10.1155/2015/138530.
8
Cirrhosis in hepatitis C virus-infected patients: a review for practitioners new to hepatitis C care.丙型肝炎病毒感染患者的肝硬化:给初涉丙型肝炎治疗的从业者的一份综述
Top Antivir Med. 2014 Sep-Oct;22(4):685-9.
9
After the cure: management of HCV after achievement of SVR.治愈后:获得 SVR 后的 HCV 管理。
Curr HIV/AIDS Rep. 2013 Dec;10(4):428-35. doi: 10.1007/s11904-013-0181-9.
10
Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients.慢性丙型肝炎患者肝纤维化和肝硬化的无创诊断。
J Clin Lab Anal. 2013 Mar;27(2):121-9. doi: 10.1002/jcla.21572. Epub 2013 Mar 4.
J Hepatol. 2001 May;34(5):730-9. doi: 10.1016/s0168-8278(00)00097-0.
4
Hepatic fibrosis. Pathogenesis and principles of therapy.肝纤维化。发病机制与治疗原则。
Clin Liver Dis. 2001 May;5(2):315-34, v-vi. doi: 10.1016/s1089-3261(05)70168-9.
5
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.丙型肝炎病毒感染患者肝纤维化的生化标志物:一项前瞻性研究。
Lancet. 2001 Apr 7;357(9262):1069-75. doi: 10.1016/S0140-6736(00)04258-6.
6
Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference.肝纤维化的机制与治疗:美国肝病研究学会单主题基础研究会议报告
Hepatology. 2000 Dec;32(6):1403-8. doi: 10.1053/jhep.2000.20243.
7
Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).
Hepatology. 2000 Sep;32(3):477-81. doi: 10.1053/jhep.2000.16602.
8
Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?慢性丙型肝炎感染中天门冬氨酸氨基转移酶与丙氨酸氨基转移酶比值:它是肝硬化的有效预测指标吗?
J Gastroenterol Hepatol. 2000 Apr;15(4):386-90. doi: 10.1046/j.1440-1746.2000.02172.x.
9
Host genetic factors influence disease progression in chronic hepatitis C.宿主遗传因素影响慢性丙型肝炎的疾病进展。
Hepatology. 2000 Apr;31(4):828-33. doi: 10.1053/he.2000.6253.
10
Which patients with hepatitis C develop liver complications?哪些丙型肝炎患者会出现肝脏并发症?
Hepatology. 2000 Feb;31(2):513-20. doi: 10.1002/hep.510310236.